Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

- Porsbjerg, Celeste M., Townend, John, Hew, Mark, Kostikas, Konstantinos, Papadopoulos, Nikolaos G., Pfeffer, Paul E., Popov, Todor A., Rhee, Chin Kook, Sadatsafavi, Mohsen, Tsai, Ming-Ju, Ulrik, Charlotte Suppli, Al-Ahmad, Mona, Bergeron, Celine, Altraja, A, Beastall, A, Bulathsinhala, L, Carter, V, Cosio, BG, Fletton, K, Hansen, S, Heaney, LG, Hubbard, RB, Kuna, P, Christoff, George C., Murray, RB, Nagano, T, Pini, L, Cano Rosales, DJ, Schleich, F, Wechsler, ME, Amaral, R, Bourdin, A, Brusselle, GG, Chen, W, Katsoulotos, Gregory P., Chung, LP, Denton, E, Fonseca, JA, Hoyte, F, Jackson, DJ, Katial, R, Kirenga, BJ, Koh, MS, Ławkiedraj, A, Lehtimäki, L, Larenas-Linnemann, Desiree, Liew, MF, Mahboub, B, Martin, N, Menzies-Gow, AN, Pang, PH, Papaioannou, AI, Patel, PH, Perez-De-Llano, L, Peters, MJ, Ricciardi, L, Tran, Tran N., Rodríguez-Cáceres, B, Solarte, I, Tay, TR, Torres-Duque, CA, Wang, E, Zappa, M, Abisheganaden, J, Assing, KD, Costello, RW, Gibson, Peter G., Al-Lehebi, Riyad, Heffler, E, Máspero, J, Nicola, S, Perng, DW, Puggioni, F, Salvi, S, Sheu, CC, Sirena, C, Taillé, C, Tan, TL, Bosnic-Anticevich, Sinthia Z., Bjermer, L, Canonica, GW, Iwanaga, T, Jiménez-Maldonado, L, Taube, C, Brussino, L, Price, DB, Busby, John

Real-world biologics response and super-response in the International Severe Asthma Registry cohort

- Denton, Eve, Hew, Mark, Larenas-Linnemann, Désirée, Murray, Ruth, Celis-Preciado, Carlos Andrés, Al-Lehebi, Riyad, Belhassen, Manon, Bhutani, Mohit, Bosnic-Anticevich, Sinthia Z., Bourdin, Arnaud, Brusselle, Guy G., Busby, John, Peters, Matthew J., Canonica, Giorgio Walter, Heffler, E, Chapman, KR, Charriot, J, Christoff, GC, Chung, LP, Cosio, BG, Côté, A, Costello, RW, Cushen, B, Upham, John W., Fingleton, J, Fonseca, JA, Gibson, Peter G., Heaney, LG, Huang, EW-C, Iwanaga, T, Jackson, DJ, Koh, MS, Lehtimäki, L, Máspero, J, Bulathsinhala, Lakmini, Mahboub, B, Menzies-Gow, AN, Mitchell, PD, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Perng, D-W, Pfeffer, PE, Popov, TA, Porsbjerg, CM, Tran, Trung N., Rhee, CK, Roche, N, Sadatsafavi, M, Salvi, S, Schmid, JM, Sheu, C-C, Sirena, C, Torres-Duque, CA, Salameh, L, Patel, PH, Martin, Neil, Ulrik, CS, Wang, E, Wechsler, ME, Price, DB, ISAR LUMINANT Working Group,, Bergeron, Celine, Al-Ahmad, Mona, Altraja, Alan

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

- Pfeffer, Paul E., Ali, Nasloon, Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al-Ahmad, Mona, Larenas-Linnemann, Désirée, Murray, Ruth, Gibson, Peter G., Fonseca, JA, Al-Lehebi, R, Rhee, CK, Perez-de-Llano, L, Perng Steve, D-W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Ulrik, Charlotte, Newell, A, Alacqua, M, Belevskiy, AS, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, AV, Busby, J, Canonica, GW, Tran, Trung N., Cosio, BG, Dorscheid, DR, Muñoz-Esquerre, M, FitzGerald, JM, Gil, EG, Gibson, PG, Heaney, LG, Hew, M, Hilberg, O, Hoyte, F, Maspero, Jorge, Jackson, DJ, Koh, MS, Ko, H-KB, Lee, JH, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, AN, Mitchell, P, Papaioannou, AI, Peters, Matthew, Popov, TA, Porsbjerg, CM, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, ME, Price, DB, Christoff, George C., Sadatsafavi, Mohsen, Torres-Duque, Carlos A.

Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry

- Chen, Wenjia, Tran, Trung N., Alacqua, Marianna, Al-Ahmad, Mona, Altraja, Alan, Al-Lehebi, Riyad, Bhutani, Mohit, Bjermer, Leif, Bjerrum, Anne-Sofie, Bourdin, Arnaud, von Bülow, Anna, Busby, John, Sadatsafavi, Mohsen, Walter Canonica, Giorgio, Carter, V, Christoff, GC, Cosio, BG, Costello, RW, Fonseca, JA, Gibson, Peter G., Yoo, K-H, Heaney, LG, Heffler, E, Murray, Ruth, Hew, M, Hilberg, O, Hoyte, F, Iwanaga, T, Jackson, DJ, Jones, RC, Koh, MS, Kuna, P, Larenas-Linnemann, D, Lehmann, S, Wong, Nigel Chong Boon, Lehtimäki, L, Lyu, J, Mahboub, B, Maspero, J, Menzies-Gow, AN, Newell, A, Sirena, C, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Ali, Nasloon, Perng Steve, D-W, Peters, M, Pfeffer, PE, Porsbjerg, CM, Popov, TA, Rhee, CK, Salvi, S, Taillé, C, Taube, C, Torres-Duque, CA, Ariti, Con, Ulrik, C, Ra, S-W, Wang, E, Wechsler, ME, Price, DB, Bulathsinhala, Lakmini, Gil, Esther Garcia, FitzGerald, J. Mark

Characterization of severe asthma worldwide: data from the International Severe Asthma Registry

- Wang, Eeileen, Wechsler, Michael E., Tran, Trung N., Heaney, Liam G., Jones, Rupert C., Menzies-Gow, Andrew N, Busby, John, Jackson, David J., Pfeffer, Paul E., Rhee, Chin Kook, Cho, You Sook, Canonica, G. Walter, Heffler, Enrico, Gibson, Peter G., Hew, Mark, Peters, Matthew, Harvey, Erin S., Alacqua, Marianna, Zangrilli, James, Bulathsinhala, Lakmini

Can biomarkers help us hit targets in difficult-to-treat asthma?

- Fricker, Michael, Heaney, Liam G., Upham, John W.

Use of biologics to treat acute exacerbations and manage disease in asthma, COPD and IPF

- Murray, Lynne A., Grainge, Chris, Wark, Peter A., Knight, Darryl A.